A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma.

[1]  Hongbing Shen,et al.  Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility. , 2013, Carcinogenesis.

[2]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[3]  Eurie L. Hong,et al.  Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.

[4]  Y. Doki,et al.  Let-7 Expression Is a Significant Determinant of Response to Chemotherapy through the Regulation of IL-6/STAT3 Pathway in Esophageal Squamous Cell Carcinoma , 2012, Clinical Cancer Research.

[5]  C. Harris,et al.  KRAS-LCS6 Genotype as a Prognostic Marker in Early-Stage CRC–Letter , 2012, Clinical Cancer Research.

[6]  Hongbing Shen,et al.  Genetic variants in human leukocyte antigen/DP‐DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development , 2012, Hepatology.

[7]  Ning Liu,et al.  Regulation of let-7 and its target oncogenes (Review). , 2012, Oncology letters.

[8]  Hongbing Shen,et al.  A Genetic Variant in the Promoter Region of miR-106b-25 Cluster and Risk of HBV Infection and Hepatocellular Carcinoma , 2012, PloS one.

[9]  R. Yang,et al.  Let-7c MicroRNA Expression and Clinical Significance in Hepatocellular Carcinoma , 2011, The Journal of international medical research.

[10]  Lingmin Hu,et al.  [Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma]. , 2011, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[11]  P. A. van den Brandt,et al.  A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer , 2011, Clinical Cancer Research.

[12]  L. Fan,et al.  Germline Genetic Variants Disturbing the Let-7/LIN28 Double-Negative Feedback Loop Alter Breast Cancer Susceptibility , 2011, PLoS genetics.

[13]  Yumei Du,et al.  Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. , 2011, Carcinogenesis.

[14]  Hongbing Shen,et al.  Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival. , 2011, American journal of respiratory and critical care medicine.

[15]  H. Kung,et al.  Hsa‐let‐7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c‐Myc and upregulation of p16INK4A , 2011, International journal of cancer.

[16]  Hongbing Shen,et al.  A potentially functional polymorphism in the promoter region of miR‐34b/c is associated with an increased risk for primary hepatocellular carcinoma , 2011, International journal of cancer.

[17]  Yuanjia Tang,et al.  Let-7/miR-98 regulate Fas and Fas-mediated apoptosis , 2011, Genes and Immunity.

[18]  Y. Jeng,et al.  Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. , 2010, Carcinogenesis.

[19]  Lewis R. Roberts,et al.  Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.

[20]  Sun-Mi Park,et al.  The role of let-7 in cell differentiation and cancer. , 2010, Endocrine-related cancer.

[21]  Peter Vajkoczy,et al.  Myeloid Zinc Finger 1 Induces Migration, Invasion, and In vivo Metastasis through Axl Gene Expression in Solid Cancer , 2010, Molecular Cancer Research.

[22]  J. Mott.  MicroRNAs involved in tumor suppressor and oncogene pathways: Implications for hepatobiliary neoplasia , 2009, Hepatology.

[23]  Brock C Christensen,et al.  A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. , 2009, Carcinogenesis.

[24]  Joel Greshock,et al.  MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. , 2008, Cancer research.

[25]  C. Croce,et al.  MicroRNA involvement in hepatocellular carcinoma , 2008, Journal of cellular and molecular medicine.

[26]  F. Slack,et al.  The let-7 family of microRNAs. , 2008, Trends in cell biology.

[27]  Hongbing Shen,et al.  Genetic variants of miRNA sequences and non-small cell lung cancer survival. , 2008, The Journal of clinical investigation.

[28]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[29]  William C Reinhold,et al.  MicroRNAs modulate the chemosensitivity of tumor cells , 2008, Molecular Cancer Therapeutics.

[30]  Patricia Soteropoulos,et al.  MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. , 2007, Cancer research.

[31]  E. Kistner,et al.  Let-7 expression defines two differentiation stages of cancer , 2007, Proceedings of the National Academy of Sciences.

[32]  Anindya Dutta,et al.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. , 2007, Genes & development.

[33]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[34]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[35]  Y. Yatabe,et al.  Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.

[36]  B. Reinhart,et al.  The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.

[37]  Hansjörg Hauser,et al.  Review: Activities of IRF-1 , 2002 .